Xbrane Biopharma Announces Reverse Share Split Ahead of Key Shareholder Meeting
Xbrane Biopharma AB, a Stockholm-based biopharmaceutical company, is set to hold an Extra General Meeting on October 13, 2025, to approve a reverse share split, which is expected to improve market perception and liquidity, and potentially pave the w…
3 minutes to read